Cover Image

Corrigendum: Effect of adjuvant therapy with compound danshen drip pill on inflammatory factors and cardiac function after percutaneous coronary intervention for acute myocardial infarction: a systematic review and meta-analysis

Saved in:

Bibliographic Details
Main Authors:	Genhao Fan (Author), Menglin Liu (Author), Huanhuan Song (Author), Yongxia Wang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of adjuvant therapy with compound danshen drip pill on inflammatory factors and cardiac function after percutaneous coronary intervention for acute myocardial infarction: a systematic review and meta-analysis
by: Genhao Fan, et al.
Published: (2024)

Proangiogenesis effects of compound danshen dripping pills in zebrafish
by: Yang-Xi Hu, et al.
Published: (2022)

Compound Danshen dripping pills prevent early diabetic retinopathy: roles of vascular protection and neuroprotection
by: Xiaoyu Xu, et al.
Published: (2024)

Coadministration of Compound Danshen dripping pills and bezafibrate has a protective effect against diabetic retinopathy
by: Le Liu, et al.
Published: (2022)

Pre-treatment with compound Danshen dripping pills prevents lipid infusion-induced microvascular dysfunction in mice
by: Yanda Zhang, et al.
Published: (2020)

Compound Danshen Dripping Pills pretreatment protects the heart from ischemia/reperfusion injury by enhancing autophagic flux
by: Haiqiong Liu, et al.
Published: (2023)

Compound Danshen Dripping Pill inhibits high altitude-induced hypoxic damage by suppressing oxidative stress and inflammatory responses
by: Yunhui Hu, et al.
Published: (2021)

Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms
by: Yanfang Yang, et al.
Published: (2023)

Protective effect of compound Danshen (Salvia miltiorrhiza) dripping pills alone and in combination with carbamazepine on kainic acid-induced temporal lobe epilepsy and cognitive impairment in rats
by: Chen Jia, et al.
Published: (2018)

Musk Tongxin Dripping Pills for treating Ticagrelor in Patients After Percutaneous Coronary Intervention: Echocardiography Combined with Untargeted Metabolomics
by: Lyu Nan, et al.
Published: (2021)

UHPLC-Q-Orbitrap HRMS and network analysis to explore the mechanisms of QiShenYiQi dripping pill for treating myocardial infarction
by: Zhichao Liu, et al.
Published: (2024)

The use of percutaneous coronary intervention in black and white veterans with acute myocardial infarction
by: Sales Anne E, et al.
Published: (2006)

Evaluation and clinical implications of interactions between compound Danshen dropping pill and warfarin associated with the epoxide hydrolase gene
by: Xixi Chen, et al.
Published: (2023)

Effect of percutaneous coronary intervention in diabetic patients with non-ST elevated myocardial infarction
by: MSI Tipu Chowdhury, et al.
Published: (2021)

DETERMINANTS OF MYOCARDIAL INFARCTION OUTCOMES IN A NON-PERCUTANEOUS CORONARY INTERVENTION HOSPITAL IN JAKARTA
by: Talitha Syifa Laili, et al.
Published: (2023)

Corrigendum: Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities
by: Jun Zhang, et al.
Published: (2022)

Machine learning for prediction of bleeding in acute myocardial infarction patients after percutaneous coronary intervention
by: Xueyan Zhao, et al.
Published: (2023)

QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology
by: Meng Li, et al.
Published: (2022)

Institutional Variance in Mortality after Percutaneous Coronary Intervention for Acute Myocardial Infarction in Korea, Japan, and Taiwan
by: Hayato Yamana, et al.
Published: (2023)

THE RELATIONSHIP OF GENDER WITH IMMEDIATE RESULTS OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION
by: N. Netyazhenko, et al.
Published: (2015)

REPERFUSION MYOCARDIAL INJURY AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENT WITH ACUTE ST-ELEVATION MYOCARDIAL INFARCTION. CLINICAL OBSERVATION
by: N. A. Kosheleva, et al.
Published: (2016)

Pharmacological effects of <it>Salvia miltiorrhiza </it>(<it>Danshen</it>) on cerebral infarction
by: Hsieh Ching-Liang, et al.
Published: (2010)

An Integrative Pharmacology-Based Pattern to Uncover the Pharmacological Mechanism of Ginsenoside H Dripping Pills in the Treatment of Depression
by: Libin Zhao, et al.
Published: (2021)

Expediency of сitoprotective treatment of patients with acute myocardial infarction, who were performed percutaneous coronary intervention
by: M. Shved, et al.
Published: (2020)

Clinical and laboratory predictors of early mortality in patients with acute myocardial infarction treated with primary percutaneous coronary intervention
by: Ružičić Dušan P., et al.
Published: (2016)

Predictors of contrast-induced nephropathy in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
by: Mohamed Abdel-Ghany, et al.
Published: (2021)

Unknown origin of acute myocardial infarction and lifesaving percutaneous coronary intervention in a 10-year-old girl
by: Münevver Tuğba Temel, et al.
Published: (2022)

Effect of the COVID-19 pandemic on access to primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
by: Göksel Çinier, et al.
Published: (2020)

Impact of Stress Hyperglycemia on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
by: Mohamed Khalfallah, et al.
Published: (2022)

Renoprotective effect of remote ischemic postconditioning in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Cao B, et al.
Published: (2018)

Effects of no-reflow phenomenon on ventricular systolic synchrony in patients with acute anterior myocardial infarction after percutaneous coronary intervention
by: Wang L, et al.
Published: (2016)

PTH Predicts the in-Hospital MACE After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction
by: Wu ZF, et al.
Published: (2023)

Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2020)

Nursing Care with NANDA Diagnosis and NIC Interventions After Acute Myocardial Infarction and Percutaneous Coronary Intervention: A Case
by: Fatma HAKYEMEZ, et al.
Published: (2021)

In-hospital outcomes of angiography versus intravascular ultrasound-guided percutaneous coronary intervention in ST-elevation myocardial infarction patients
by: Mazin Khalid, et al.
Published: (2020)

Qingnao dripping pills mediate immune-inflammatory response and MAPK signaling pathway after acute ischemic stroke in rats
by: Zixiu Zeng, et al.
Published: (2019)

Incidence, Predictors and Outcomes of Contrast Induced Nephropathy in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
by: Mohamed Khalfallah, et al.
Published: (2021)

Discharge Hemoglobin Association with Long-Term Outcomes of ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
by: Ming Gao, et al.
Published: (2020)

Prognostic Value of Pentraxin-3 Change After Primary Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction
by: Li SY, et al.
Published: (2023)

The Effects of Aspirin With Combined Compound Danshen Dropping Pills on Hemorheology and Blood Lipids in Middle-Aged and Elderly Patients With CHD: A Systematic Review and Meta-Analysis
by: Zhi Liu, et al.
Published: (2021)